Key result
Balloon aortic valvuloplasty in patients ≥90 years with severe aortic stenosis was feasible, with a 30-day mortality of 9.7% and an increase in mean aortic valve area from 0.52 to 0.92 cm2.
Why the study?
Is balloon aortic valvuloplasty feasible and safe for treating severe aortic stenosis in patients ≥90 years of age?
Observational (n=31)
No
Is balloon aortic valvuloplasty feasible and safe for treating severe aortic stenosis in patients ≥90 years of age?
Balloon aortic valvuloplasty is a feasible and relatively safe palliative option for nonagenarians with severe aortic stenosis who are at prohibitive surgical risk.
Authors
No takes yet. Share an insight, caveat, or question.
Supports BAV feasibility in selected nonagenarians; leaves open comparative outcomes versus TAVR or medical therapy.
Pedersen et al. (2007) conducted an observational in Severe aortic stenosis (n=31). Balloon aortic valvuloplasty (BAV) was evaluated on 30-day mortality. Balloon aortic valvuloplasty in patients ≥90 years with severe aortic stenosis was feasible, with a 30-day mortality of 9.7% and an increase in mean aortic valve area from 0.52 to 0.92 cm2.